Meet Proteona at the BioRN Annual Conference 2020
Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology
Proteona will attend the BioRN Annual Conference 2020, taking place on Friday, the 20th of November 2020.
This year’s conference, focusing on the topic of “Precision Technologies 4 Life”, will be delivered virtually. It will feature keynote presentations on using molecular profiling to improve disease detection and precision medicine. Register now to schedule one-to-one meetings with Proteona.
Check out the BioRN 2020 conference program here!
For media queries, please contact:
Dr Andreas Schmidt
Proteona Pte. Ltd. is a biomedical company in Singapore, Germany, and the US that is pioneering the use of single cell proteogenomics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona provides a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR). Proteona is leading an international alliance to develop neutralizing antibodies against coronaviruses including SARS-CoV-2. In addition, Proteona supports partners developing COVID-19 therapies and vaccines by providing single cell immune profiling services.